Correlation Between InBody CoLtd and INtRON Biotechnology

Can any of the company-specific risk be diversified away by investing in both InBody CoLtd and INtRON Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining InBody CoLtd and INtRON Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between InBody CoLtd and iNtRON Biotechnology, you can compare the effects of market volatilities on InBody CoLtd and INtRON Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in InBody CoLtd with a short position of INtRON Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of InBody CoLtd and INtRON Biotechnology.

Diversification Opportunities for InBody CoLtd and INtRON Biotechnology

0.73

Correlation Coefficient

InBody CoLtd  INtRON Biotechnology

Poor diversification

The 3 months correlation between InBody and INtRON is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding InBody CoLtd and iNtRON Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iNtRON Biotechnology and InBody CoLtd is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on InBody CoLtd are associated (or correlated) with INtRON Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iNtRON Biotechnology has no effect on the direction of InBody CoLtd i.e., InBody CoLtd and INtRON Biotechnology go up and down completely randomly.

Pair Corralation between InBody CoLtd and INtRON Biotechnology

Assuming the 90 days trading horizon InBody CoLtd is expected to under-perform the INtRON Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, InBody CoLtd is 1.57 times less risky than INtRON Biotechnology. The stock trades about -0.1 of its potential returns per unit of risk. The iNtRON Biotechnology is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest  705,000  in iNtRON Biotechnology on September 24, 2024 and sell it today you would lose (166,000) from holding iNtRON Biotechnology or give up 23.55% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

InBody CoLtd  vs.  iNtRON Biotechnology

InBody CoLtd

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days InBody CoLtd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

iNtRON Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days iNtRON Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, INtRON Biotechnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with InBody CoLtd and INtRON Biotechnology

The main advantage of trading using opposite InBody CoLtd and INtRON Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if InBody CoLtd position performs unexpectedly, INtRON Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INtRON Biotechnology will offset losses from the drop in INtRON Biotechnology's long position.

The idea behind InBody CoLtd and iNtRON Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.